Acrivon Therapeutics, Inc. ("Acrivon” or "Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage precision medicine company ...

The virus takes control of three key host proteins that suppress the activity of the complement system. Researchers at the ...

Tiny lab-grown models of human immune systems are helping researchers understand why cancer patients struggle to fight ...

Key areas of interest include: 1. Identification of immune cell subsets and their roles in disease pathogenesis 2. Understanding the genetic and environmental factors that influence immune responses, ...